Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

CVS program seeks to encourage genetic testing of cancer patients

December 13, 2019 9:08 PM UTC
Updated on Dec 14, 2019 at 12:03 AM UTC

CVS is addressing the disconnect between availability of targeted cancer therapies and limited access to genetic tests through a precision medicine program that encourages next generation sequencing at the point of diagnosis.

The CVS Health Corp. (NYSE:CVS) program, dubbed Transform Oncology Care, is offered through an online provider portal that makes NGS panels available to providers at the point of diagnosis, and uses the genomic test results at the point of prescribing to connect patients with the appropriate therapies as quickly as possible. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Aetna Inc.

Cvs Health Corp.